Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study

Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study

Background. The prevalence of heart failure with preserved ejection fraction (HFpEF) in patients with antiphospholipid syndrome (APS) is unknown. Methods. A prospective multicenter cohort study including 125 patients was conducted: 91 primary APS (PAPS), 18 APS-SLE, and 16 carriers. HFpEF was diagno...

Full description

Bibliographic Details
Main Authors: Daniele Pastori, Paul R. J. Ames, Massimo Triggiani, Antonio Ciampa, Vittoria Cammisotto, Roberto Carnevale, Pasquale Pignatelli, Tommaso Bucci, on behalf of the ATHERO-APS Study Group
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
antiphospholipid syndrome
HFpEF
echocardiography
heart failure
Online Access:https://www.mdpi.com/2077-0383/10/14/3180

Internet

https://www.mdpi.com/2077-0383/10/14/3180

Similar Items